PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9576847-7 1998 Although the two AKR7 proteins are predicted to possess distinct secondary structural features which distinguish them from the prototypic AKR1 family of AKRs, the catalytic- and NADPH-binding residues appear to be conserved in both families. NADP 178-183 aldo-keto reductase family 7 member A2 Homo sapiens 17-21 11409944-7 2001 One enzyme induced by cancer chemopreventive agents is AFB1 aldehyde reductase (AFAR), which catalyzes the NADPH-dependent reduction of the dialdehyde to a dialcohol. NADP 107-112 aldo-keto reductase family 7 member A2 Homo sapiens 55-78 11409944-7 2001 One enzyme induced by cancer chemopreventive agents is AFB1 aldehyde reductase (AFAR), which catalyzes the NADPH-dependent reduction of the dialdehyde to a dialcohol. NADP 107-112 aldo-keto reductase family 7 member A2 Homo sapiens 80-84 7424738-7 1980 The fourth human brain enzyme ("SSA reductase") differs from the other forms in its ability to use NADH as well as or better than NADPH as cofactor, and in its molecular weight, which is nearly twice that of the other forms. NADP 130-135 aldo-keto reductase family 7 member A2 Homo sapiens 17-46 17591773-3 2007 The human aldo-keto reductase AKR7A2 has been proposed previously to catalyze the NADPH-dependent reduction of succinic semialdehyde (SSA) to GHB in human brain. NADP 82-87 aldo-keto reductase family 7 member A2 Homo sapiens 30-36